Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Einhorn’s Top New Stock Picks Include General Motors Company (GM), Macy’s, Inc. (M), Sunedison Semiconductor Ltd (SEMI)

Page 1 of 2

David Einhorn’s Greenlight Capital has filed its 13F with the SEC for the reporting period of March 31. Einhorn is known for his long/short equity investments and is rated as one of the best hedge fund managers in the world today. According to Forbes, Einhorn has a current net worth of $1.92 billion and he ranks at number 18 in Forbes’ list of the richest hedge fund managers. Greenlight Capital has an investment portfolio valued at $7.65 billion with its top ten stock holdings accounting for 62.95% of its concentrated portfolio. Einhorn invests nearly half of his money in the technology sector, with the consumer discretionary and industrial sectors getting big chunks of the remaining pie. Apple Inc. (NASDAQ:AAPL), Micron Technology, Inc. (NASDAQ:MU) and Sunedison Inc (NYSE:SUNE) are among the largest stock picks of Einhorn, but we’ll spend this article looking at Einhorn’s newly initiated positions, of which there were seven during the first quarter. General Motors Company (NYSE:GM), Macy’s, Inc. (NYSE:M), and Sunedison Semiconductor Ltd (NASDAQ:SEMI) are the top three of those new stock picks of the billionaire investment manager.

Greenlight Capital

Professional investors like Einhorn spend considerable time and money conducting due diligence on each company they invest in, which makes them the perfect investors to emulate. However, while Einhorn’s returns have been strong throughout his tenure at Greenlight, we also know that the returns of hedge funds on the whole have not been good for several years, underperforming the market. We analyzed the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better than their large-cap picks, which is where most of their money is invested and why their performances as a whole have been poor. A portfolio of the 15 most popular small-cap stocks among funds outperformed the S&P 500 Total Return Index by an average of 95 basis points per month between 1999 and 2012 in backtesting. The exceptional results of this strategy got even better in forward testing after the strategy went live at the end of August 2012. A portfolio consisting of the 15 most popular small-cap stock picks among the funds we track has returned more than 139% and beaten the market by more than 80 percentage points since then, and by 4.6 percentage points in the first quarter of this year (see the details).

General Motors Company (NYSE:GM) is the top new stock pick of Einhorn, with his current position in the automobile company amounting to 9.47 million shares with a market value of $355.04 million. With stiff competition from other brands such as Ford Motor Company (NYSE:F) in the muscle car segment, General Motors recently unveiled the 2016 model of the Chevrolet Camaro. Camaro will help the company compete against other leading muscle car manufacturers and its primary competition includes the Ford Mustang and Chrysler Hemi Hellcat Challenger. Earlier last week, General Motors Company (NYSE:GM)’s China division announced a price cut to all primary brands of the company including Cadillac, Buick, and Chevrolet. The Chinese automobile industry is facing a slowdown and the majority of car brands are cutting prices to kickstart sales. Warren Buffett‘s Berkshire Hathaway, Appaloosa Management, and Taconic Capital hold major positions in the American automaker.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!